Evidence map›Paper›PMID 28352656›Full record

ArticleJCI insight2017

Trafficking receptor signatures define blood plasmablasts responding to tissue-specific immune challenge.

Yekyung Seong, Nicole H Lazarus, Lusijah Sutherland, Aida Habtezion, Tzvia Abramson, Xiao-Song He, Harry B Greenberg, Eugene C Butcher

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Group AScience immunology · 2023
    Article
  6. Review
  7. Article
  8. B cells defined by immunoglobulin isotypes.Clinical and experimental immunology · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yekyung SeongLaboratory of Immunology and Vascular Biology, Department of Pathology, Stanford University School of Medicine, Stanford, California, USA and the Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.
Nicole H LazarusLaboratory of Immunology and Vascular Biology, Department of Pathology, Stanford University School of Medicine, Stanford, California, USA and the Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.
Lusijah SutherlandLaboratory of Immunology and Vascular Biology, Department of Pathology, Stanford University School of Medicine, Stanford, California, USA and the Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.
Aida HabtezionDivision of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA.
Tzvia AbramsonSan Jose State University, Department of Biology, San Jose, California, USA.
Xiao-Song HeThe Center for Molecular Biology and Medicine, Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.
Harry B GreenbergThe Center for Molecular Biology and Medicine, Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.
Eugene C ButcherLaboratory of Immunology and Vascular Biology, Department of Pathology, Stanford University School of Medicine, Stanford, California, USA and the Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.
VA Palo Alto Health Care System · USStanford University · US

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune ProfilingU01AI089859 · NIAID · MAYO CLINIC ROCHESTER · PI POLAND, GREGORY A. · 2010 to 2015
$33.8M
Vaccination and infection: indicators of immunological health and responsivenessU19AI090019 · NIAID · STANFORD UNIVERSITY · PI DAVIS, MARK MORRIS · 2010 to 2015
$17.3M
VIRAL GASTROENTERITIS--BASIS OF PROTECTION AND VIRULENCER01AI021362 · NIAID · STANFORD UNIVERSITY · PI GREENBERG, HARRY BERNARD · 1989 to 2014
$5.4M
Intestinal Lymphocyte TraffickingR01AI047822 · NIAID · STANFORD UNIVERSITY · PI EUGENE C BUTCHER · 2001 to 2026
$4.7M
Intestinal Lymphocyte TraffickingR37AI047822 · NIAID · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI BUTCHER, EUGENE C · 2011 to 2020
$3.5M
Role and Regulation of colon Trafficking Novel G-Protein Coupled ReceptorsR01DK101119 · NIDDK · STANFORD UNIVERSITY · PI HABTEZION, AIDA · 2016 to 2019
$2.0M
Mucosal and Systemic Immune Responses to Influenza VirusU01AI115715 · NIAID · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI GREENBERG, HARRY BERNARD · 2015 to 2017
$1.3M
VIRAL GASTROENTERITIS--BASIS OF PROTECTION AND VIRULENCER37AI021362 · NIAID · STANFORD UNIVERSITY · PI GREENBERG, HARRY BERNARD · 1994 to 2003
$789k
Viral Gastroenteritis: Basis of Virulence and ProtectionR56AI021362 · NIAID · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI GREENBERG, HARRY BERNARD · 2015 to 2015
$506k
Mucosal Immunity and Influenza Vaccines: Phenotype and Role of Activated B CellsRC1AI087257 · NIAID · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI BUTCHER, EUGENE C, GREENBERG, HARRY BERNARD · 2010 to 2010
$492k
CCR9 AND TECK IN INTESTINAL LYMPHOCYTE TRAFFICKINGR21AI047822 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI BUTCHER, EUGENE C · 2000 to 2000
$258k
NIAID NIH HHS R01 AI021362NIAID NIH HHS R01 AI047822NIAID NIH HHS R21 AI047822NIAID NIH HHS R37 AI021362NIAID NIH HHS R37 AI047822NIAID NIH HHS R56 AI021362NIAID NIH HHS RC1 AI087257NIAID NIH HHS U01 AI089859NIAID NIH HHS U01 AI115715NIAID NIH HHS U19 AI057229NIAID NIH HHS U19 AI090019NIDDK NIH HHS R01 DK101119
6 · The paper itself

Abstract

Antibody-secreting cells are generated in regional lymphoid tissues and traffic as plasmablasts (PBs) via lymph and blood to target sites for local immunity. We used multiparameter flow cytometry to define PB trafficking programs (TPs, combinations of adhesion molecules and chemoattractant receptors) and their imprinting in patients in response to localized infection or immune insults. TPs enriched after infection or autoimmune inflammation of mucosae correlate with sites of immune response or symptoms, with different TPs imprinted during small intestinal, colon, throat, and upper respiratory immune challenge. PBs induced after intramuscular or intradermal influenza vaccination, including flu-specific antibody-secreting cells, display TPs characterized by the lack of mucosal homing receptors. PBs of healthy donors display diverse mucosa-associated TPs, consistent with homeostatic immune activity. Identification of TP signatures of PBs may facilitate noninvasive monitoring of organ-specific immune responses.

Indexed as

Antibody FormationAntibody-Producing CellsBiological TransportCeliac DiseaseColitis, UlcerativeHumansImmunity, MucosalLymphoid TissueRespiratory Tract InfectionsStreptococcal Infections

Identifiers

PMID28352656
PMCPMC5358486
OpenAlexW2598981127

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.